Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs LII✓SelectedUSD · LIIMRNA vs LII performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs LII

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.0%
LII return
+9.4%
Excess return
-40.4%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioLIIExcessAlpha
1D-2.2%-2.4%+0.2%-0.9%
7D-12.7%-5.0%-7.7%-10.3%
30D-20.7%-8.7%-12.0%-17.6%
3M+46.3%-17.3%+63.6%+59.7%
6M+305.2%-31.8%+337.0%+379.1%
YTD+561.2%-30.5%+591.7%+659.7%
1Y+772.1%-23.8%+795.9%+851.1%
3Y+147.0%-15.5%+162.4%+156.2%
All-31.0%+9.4%-40.4%-48.0%

Cumulative growth

Daily Returns

Daily percentage return beside LII.

Daily Out/Under-Performance

Portfolio return minus LII return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × LII return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded LII wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling